Enovis Corp

NYSE ENOV

Data sourced from

and

Download Data

Enovis Corp Days Inventory Outstanding (DIO) 1 year YoY Change (%) for the quarter ending March 31, 2024: 4.59%

Enovis Corp Days Inventory Outstanding (DIO) 1 year YoY Change (%) is 4.59% for the quarter ending March 31, 2024, a -94.15% change year over year. The days inventory outstanding ratio measures the average number of days it takes for a company to sell its inventory. It is calculated by dividing inventory by the cost of revenue and then multiplying by 365. This ratio indicates the average number of days inventory is held before being sold. A lower number of days suggests faster inventory turnover and efficient inventory management. The measure "Change (%)" refers to the percentage change in the value of a financial metric between two time points. This measure provides a relative perspective on the magnitude of change.

Enovis Corp Days Inventory Outstanding (DIO) for the quarter ending March 31, 2023 was 936.48, a 78.45% change year over year.
Enovis Corp Days Inventory Outstanding (DIO) for the quarter ending March 31, 2022 was 524.80, a 20.52% change year over year.
Enovis Corp Days Inventory Outstanding (DIO) for the quarter ending March 31, 2021 was 435.45, a -0.57% change year over year.
Enovis Corp Days Inventory Outstanding (DIO) for the quarter ending March 31, 2020 was 437.93, a 5.35% change year over year.

NYSE: ENOV

Enovis Corp

CEO	Mr. Mitchell P. Rales
IPO Date	May 8, 2008
Location	United States
Headquarters	2711 Centerville Road, Wilmington, DE, United States, 19808
Employees	6,550
Sector	Industrials
Industry	Specialty industrial machinery

Description

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.

Key trends